STEM CELL SCIENCES, INC. (SCS) is a privately owned, NYSDOH licensed comprehensive stem cell bank, registered with the FDA and approved for the procurement, processing, storage and distribution of human hematopoietic (blood forming) stem cells of bone marrow and peripheral blood origin. Stem cells collected and processed by us have been successfully used since 1993 for the engraftment of many patients with diagnosis of cancer (Acute and Chronic Leukemia, Lymphomas, both Hodgkin’s and Non-Hodgkin’s, Multiple Myeloma, Breast Cancer and other solid tumors) that were treated at several premier New York Hospitals.
In addition to its activity related to established therapeutic usage of hematopoietic stem cells for the treatment of cancer, the company is also engaged in bench research of marrow derived mesenchymal (stromal/non-blood forming) stem cells for future clinical applications in the treatment of joint diseases as well as inflammatory bowel diseases and certain auto-immune disorders.
SCS facility is located in midtown Manhattan with available space of approx. 3000 sq. ft. comprising an apheresis suite for peripheral blood stem cells collections, a stem cell laboratory, medical offices and examination rooms properly equipped to allow bone marrow aspiration sampling.
The stem cell laboratory hosts the necessary equipment for the large scale processing of stem cells under sterile conditions, short and long term in-vitro culture of stem cells, liquid nitrogen storage as well as microscopy and PCR capabilities for research purposes.
SCS intends to continue its excellence in banking hematopoietic stem cells for the treatment of certain cancers and to establish itself as a facility dedicated to advance marrow-derived stromal stem cell research in preparation for clinical applications.